Sustained suppression of choroidal neovascularization by intraocularly stable tetrahedral network encapsulated miR-22–3p
Source abstract
Abstract
Choroidal neovascularization (CNV), characterized by abnormal vessel growth and vascular leakage, is the hallmark of wet age-related macular degeneration (wAMD) and a leading cause of irreversible vision loss. Although anti-vascular endothelial growth factor (VEGF) therapies remain the current standard, their frequent administration and limited long-term efficacy highlight the need for novel treatments. Here, we developed a miR-22-3p-loaded tetrahedral framework nucleic acids (tFNAs-miR22) nanostructure and evaluated its efficacy in CNV suppression. The nanocomplex was structurally validated, exhibiting high assembly fidelity and superior intraocular stability compared to serum conditions. In a laser-induced CNV mouse model, a single intravitreal injection of tFNAs-miR22 significantly reduced lesion size and leakage by day 10, with efficacy comparable to aflibercept. In a rat model of stable and long-lasting CNV, tFNAs-miR22 demonstrated durable inhibition of vascular leakage by Day 21, showing greater persistence compared to aflibercept. This effect was dose-dependent, with the high-dose group outperforming aflibercept in suppressing leakage. Transcriptomic profiling of hypoxia-challenged HUVECs further revealed that tFNAs-miR22 modulates angiogenic pathways, including suppression of the phosphoinositide 3-kinase (PI3K)/protein kinase B (AKT)/mechanistic target of rapamycin (mTOR) axis. These findings demonstrate the potent and long-lasting therapeutic effects of tFNAs-miR22, supporting its promise as a next-generation, gene-regulatory nanotherapy for sustained inhibition of CNV.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Retinal Diseases and Treatments · Nanoplatforms for cancer theranostics · RNA Interference and Gene Delivery
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (39)
Show source-provided references
1. Age-related macular degeneration10.1258/jrsm.2009.080298 ↗
2. Global burden of low vision and blindness due to age-related macular degeneration from 1990 to 2021 and projections for 205010.1186/s12889-024-21047-x ↗
3. Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis10.1016/S2214-109X(13)70145-1 ↗
4. Neovascular age-related macular degeneration10.1159/000438969 ↗
5. Photoreceptor loss in age-related macular degeneration
6. Subretinal fibrosis in neovascular age-related macular degeneration: current concepts, therapeutic avenues, and future perspectives10.1007/s00441-021-03514-8 ↗
7. Ranibizumab versus verteporfin for neovascular age-related macular degeneration10.1056/NEJMoa062655 ↗
8. Treatment burden in neovascular AMD:Visual acuity outcomes are associated with Anti-VEGF injection frequency10.3928/23258160-20170928-01 ↗
9. Incomplete response to Anti-VEGF therapy in neovascular AMD: exploring disease mechanisms and therapeutic opportunities10.1016/j.preteyeres.2020.100906 ↗
10. Risk of geographic atrophy in the comparison of age-related macular degeneration treatments trials10.1016/j.ophtha.2013.08.015 ↗
11. Intravitreal ranibizumab May induce retinal arteriolar vasoconstriction in patients with neovascular age-related macular degeneration10.1016/j.ophtha.2009.03.017 ↗
12. MicroRNAs as potential biomarkers and therapeutic targets in age-related macular degeneration
13. Suppression of endothelial miR-22 mediates non-small cell lung cancer cell-induced angiogenesis10.1016/j.omtn.2021.10.003 ↗
14. miR-22-3p suppresses endothelial progenitor cell proliferation and migration via inhibiting onecut 1 (OC1)/Vascular endothelial growth factor A (VEGFA) signaling pathway and its clinical significance in venous thrombosis10.12659/MSM.925482 ↗
15. MiR-22-3p suppresses vascular remodeling and oxidative stress by targeting CHD9 during the development of hypertension10.1159/000514311 ↗
16. MicroRNA-22-3p ameliorates Alzheimer's disease by targeting SOX9 through the NF-κB signaling pathway in the hippocampus10.1186/s12974-022-02548-1 ↗
17. Trials and tribulations of MicroRNA therapeutics10.3390/ijms25031469 ↗
18. The application of tetrahedral framework nucleic acids as a drug carrier in biomedicine fields10.2174/1574888X15666200422103415 ↗
19. Systematic study in mammalian cells showing no adverse response to tetrahedral DNA nanostructure10.1021/acsami.8b02626 ↗
20. Progress in biomedical applications of tetrahedral framework nucleic acid-based functional systems10.1021/acsami.0c13806 ↗
21. Anti-inflammatory and antioxidative effects of tetrahedral DNA nanostructures via the modulation of macrophage responses10.1021/acsami.7b17928 ↗
22. Tetrahedral framework nucleic acids inhibit pathological neovascularization and vaso-obliteration in ischaemic retinopathy via PI3K/AKT/mTOR signalling pathway10.1111/cpr.13407 ↗
23. Tetrahedral framework nucleic acids prevent retina ischemia-reperfusion injury from oxidative stress via activating the Akt/Nrf2 pathway10.1039/C9NR07171G ↗
24. Tetrahedral framework nucleic acids promote corneal epithelial wound healing in vitro and in vivo
25. Ocular drug delivery to the retina: current innovations and future perspectives10.3390/pharmaceutics13010108 ↗
26. Laser-induced choroidal neovascularization model to study age-related macular degeneration in mice10.1038/nprot.2013.135 ↗
27. Inhibition of choroidal neovascularization by homoisoflavanone, a new angiogenesis inhibitor
28. Hydrogen peroxide-induced oxidative damage and protective role of peroxiredoxin 6 protein via EGFR/ERK signaling pathway in RPE cells10.3389/fnagi.2023.1169211 ↗
29. Age-related macular degeneration: role of oxidative stress and blood vessels10.3390/ijms22031296 ↗
30. The current progress of tetrahedral DNA nanostructure for antibacterial application and bone tissue regeneration10.2147/IJN.S403882 ↗
31. DNA tetrahedra-based delivery of MicroRNA-22 to reduce depressive symptoms in mice10.1021/acsami.3c03054 ↗
32. Fluorescence coupled capillary electrophoresis as a strategy for tetrahedron DNA analysis10.1016/j.talanta.2021.122225 ↗
33. The single-step synthesis of a DNA tetrahedron10.1039/b402293a ↗
34. Purification of self-assembled DNA tetrahedra using gel electrophoresis10.1002/cpz1.560 ↗
35. Loop-armed DNA tetrahedron nanoparticles for delivering antisense oligos into bacteria10.1186/s12951-020-00667-6 ↗
36. Effect of zeta potential on the properties of nano-drug delivery systems - a review (part 1)
37. A replicable tetrahedral nanostructure self-assembled from a single DNA strand10.1021/ja903768f ↗
38. Treatment efficacy of a dual release of aflibercept and dexamethasone from a single hydrogel drug delivery system in a rodent model10.1167/tvst.14.6.31 ↗
39. Role of akt signaling in vascular homeostasis and angiogenesis10.1161/01.RES.0000022200.71892.9F ↗